Immune-Related Adverse Events Caused by Immune Checkpoint Inhibition

Bristol Myers Squibb
September 7, 2021

This presentation will provide an introduction to the immune system and immuno-oncology and educate on some of the immune-related adverse events (irAEs) that can result from immune checkpoint inhibition. We will also review signs and symptoms of select irAEs and provide a summary of general management principles for select irAEs.